LG-611

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLG-611
Drug Alias Namepandemic influenza vaccine (PATH/Lentigen)pandemic influenza vaccine (PATH/Lentigen)LG-611
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLentigen Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPathLentigen Technology Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A